Ownership and insider activity for PAVmed Inc. (PAVM): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay.
Price
| Price | $3.92 |
| Market Cap | $25M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-04-02 | Lee Victoria Tou-ho | A-Award | 70,000 | |
| 2026-03-24 | Lee Victoria Tou-ho | |||
| 2026-03-27 | Tasso Partners, LLC | |||
| 2026-02-03 | Tasso Partners, LLC | 5,365 | $5.4M | |
| 2026-04-02 | Aklog Lishan | A-Award | 350,000 | |
| 2026-04-02 | MCGRATH DENNIS M | A-Award | 180,000 | |
| 2026-04-02 | Glennon Michael J | A-Award | 13,930 | |
| 2026-04-02 | Baxter Timothy E | A-Award | 13,930 | |
| 2026-04-02 | White Debra | A-Award | 13,930 | |
| 2026-04-02 | Sparks Ronald M | A-Award | 13,930 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $585680 | $1.5M | $8.2M | $6.2M | $17.3M | $77.3M | $39.7M | $19.6M | $1.2M | $1.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | $262000 | $2.0M | $3.0M | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | $200000 | $17000 | $61000 | $18000 | $15000 |
| Inventory | 0 | 0 | 0 | 0 | $855000 | $526000 | $261000 | $539000 | $266000 | $239000 |
| Total Current Assets | $741170 | $1.6M | $8.5M | $6.5M | $18.9M | $82.6M | $43.9M | $24.5M | $2.2M | $2.6M |
| Property, Plant & Equipment | $18000 | $16191 | $36271 | 0 | $82000 | $1.6M | $5.5M | $6.0M | $2.7M | $2.1M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | $2.0M | $3.4M | $1.4M | 0 | 0 |
| Total Assets | $870419 | $1.6M | $8.5M | $7.2M | $19.8M | $87.0M | $54.0M | $33.1M | $30.7M | $38.8M |
| Accounts Payable | $949413 | $864405 | $1.7M | $2.4M | $3.0M | $3.3M | $2.7M | $1.8M | $657000 | $678000 |
| Short-term Debt | 0 | 0 | $7.9M | $8.1M | $15.0M | 0 | $33.6M | $44.2M | $29.1M | $11.1M |
| Total Current Liabilities | $1.2M | $2.5M | $11.0M | $11.9M | $20.3M | $7.6M | $41.2M | $54.2M | $35.4M | $14.8M |
| Long-term Debt | 0 | $1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $1.2M | $4.5M | $11.0M | $11.9M | $20.3M | $7.6M | $43.0M | $57.1M | $37.7M | $16.5M |
| Retained Earnings | -$7.7M | -$17.9M | -$37.0M | -$53.7M | -$88.3M | -$138.9M | -$228.2M | -$294.4M | -$255.0M | -$258.7M |
| Total Equity | -$319067 | -$2.8M | -$2.3M | -$3.8M | $1.9M | $61.7M | -$9.7M | -$53.8M | -$2.5M | $34.0M |
| Total Debt | 0 | $1.9M | $7.9M | $8.1M | $15.0M | 0 | $36.6M | $48.7M | $31.9M | $13.3M |
| Net Debt | -$585680 | $409246 | -$319119 | $1.9M | -$2.6M | -$79.2M | -$6.1M | $29.1M | $30.7M | $11.8M |
| Working Capital | -$448316 | -$920280 | -$2.5M | -$5.3M | -$1.3M | $75.1M | $2.7M | -$29.7M | -$33.3M | -$12.3M |
Financial Health
| Debt / Equity | 0.49 |
| Current Ratio | 1.19 |
Profitability
| Return on Equity | -33.51% |
| Return on Invested Capital | -72.77% |
| Return on Assets | -30.06% |
| Gross Margin | -254.46% |
| Operating Margin | -23842.86% |
| Net Margin | -10794.64% |
Related companies: ADVB · APVO · BMRA · BNR · DHAI · HSCS · IINN
Explore sector: Healthcare · Medical - Devices
More sections of PAVM: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks